Skip to content

Net Income at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
-$132.73M-136%
ALN
Alnylam PharmaceuticalsALNY
$205.99M+1,229%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
-$19.63M-49.3%
Arbutus Biopharma Corporation logo
Arbutus Biopharma CorporationABUS
$169.7M+792%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
-$125.7M-3.9%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
-$3.73M+87.5%

Other financials

Income statement

See full
Revenue$8.2M-12.8%
Operating income-$11.4M-14.4%
EPS (diluted)-$0.54+53.8%

Balance sheet

See full
Cash & equivalents$31.1M+32.9%
Total debt$2.5M-17.5%
Total equity$198.6M+632%
Total assets$235.5M+138%

Cash flow

See full
Operating cash flow-$22.1M+5.7%
CapEx$19.0K
Free cash flow-$22.1M+5.6%

Valuation

See full
Market cap$480.77M+262%
Enterprise value$452.14M+302%
P/S6.8×+2.6×

Profitability

See full
Operating margin-116.8%-26.1pp
Net margin-103.6%-22.7pp
FCF margin-150%-231pp

Returns & leverage

See full
Return on equity-36.9%-15.1pp
Debt / equity-0.1×
Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Assembly Biosciences's net income?
Assembly Biosciences (ASMB) reported net income of -$9.08M in Q1 2026.
How has Assembly Biosciences's net income changed year-over-year?
Assembly Biosciences's net income decreased by 3.0% year-over-year, from -$8.82M to -$9.08M.
What is the long-term trend for Assembly Biosciences's net income?
Over 3 years (2021 to 2024), Assembly Biosciences's net income has grown at a -32.4% compound annual growth rate (CAGR), from -$129.86M to -$40.18M.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.